Last $68.67 USD
Change Today -0.19 / -0.28%
Volume 2.4M
BAX On Other Exchanges
New York
SIX Swiss Ex
As of 4:15 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert M. Davis J.D.

Former Corporate Vice President and President of Medical Products, Baxter International Inc.
AgeTotal Calculated CompensationThis person is connected to 1 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert M. Davis, also known as Rob, served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since April 23, 2014. He was an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President at Renal at Baxter International Inc. from July ...

Read Full Background

Corporate Headquarters*

One Baxter Parkway
Deerfield, Illinois 60015

United States

Phone: 224-948-2000
Fax: 224-948-1813

Board Members Memberships*

Former Trustee


Bachelor's Degree
Miami University
Northwestern University School of Law
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$742,308

Stock Options*

Restricted Stock Awards$1,096,573
All Other Compensation$72,905
Exercised Options133,800
Exercised Options Value$2,841,792
Exercisable Options211,283
Exercisable Options Value$2,619,721
Unexercisable Options206,141
Unexercisable Options Value$1,155,852
Total Value of Options$6,617,364
Total Number of Options551,224

Total Compensation*

Total Annual Cash Compensation$1,587,713
Total Short Term Compensation$742,308
Other Long Term Compensation$1,169,478
Total Calculated Compensation$4,212,953
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAX:US $68.67 USD -0.19


Kevin A. Lobo Chairman, Chief Executive Officer and President
Stryker Corporation
Thomas J. Falk Executive Chairman, Chief Executive Officer, President and Member of Executive Committee
Kimberly-Clark Corporation
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAXTER INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at